CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival

por Szuber, Natasha, Finke, Christy M., Lasho, Terra L., Elliott, Michelle A., Hanson, Curtis A., Pardanani, Animesh, Tefferi, Ayalew
Publicado 2018

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions

por Tefferi, Ayalew, Finke, Christy M., Lasho, Terra L., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh
Publicado 2018

Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms

por Lasho, Terra L., Vallapureddy, Rangit, Finke, Christy M., Mangaonkar, Abhishek, Gangat, Naseema, Ketterling, Rhett, Tefferi, Ayalew, Patnaik, Mrinal M.
Publicado 2018

EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental

por Patnaik, Mrinal M., Vallapureddy, Rangit, Lasho, Terra L., Hoversten, Katherine P., Finke, Christy M., Ketterling, Rhett, Hanson, Curtis, Gangat, Naseema, Tefferi, Ayalew
Publicado 2018

Genetic predictors of response to specific drugs in primary myelofibrosis

por Penna, Domenico, Szuber, Natasha, Lasho, Terra L., Finke, Christy M., Vallapureddy, Rangit R., Hanson, Curtis A., Ketterling, Rhett P., Pardanani, Animesh, Gangat, Naseema, Tefferi, Ayalew
Publicado 2018

A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy

por Gangat, Naseema, Phelps, Amy, Lasho, Terra L., Finke, Christy M., Vallapureddy, Rangit, Hanson, Curtis A., Ketterling, Rhett P., Patnaik, Mrinal M., Pardanani, Animesh, Tefferi, Ayalew
Publicado 2019

Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model

por Vallapureddy, Rangit R., Mudireddy, Mythri, Penna, Domenico, Lasho, Terra L., Finke, Christy M., Hanson, Curtis A., Ketterling, Rhett P., Begna, Kebede H., Gangat, Naseema, Pardanani, Animesh, Tefferi, Ayalew
Publicado 2019

Mutations and thrombosis in essential thrombocythemia

por Guglielmelli, Paola, Gangat, Naseema, Coltro, Giacomo, Lasho, Terra L., Loscocco, Giuseppe Gaetano, Finke, Christy M., Morsia, Erika, Sordi, Benedetta, Szuber, Natasha, Hanson, Curtis A., Pardanani, Animesh, Vannucchi, Alessandro M., Tefferi, Ayalew
Publicado 2021

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

por Bezerra, Evandro D., Lasho, Terra L., Finke, Christy M., Saliba, Antoine N., Elliott, Michelle A., Pardanani, Animesh D., Gangat, Naseema, Mangaonkar, Abhishek A., Ketterling, Rhett P., Tefferi, Ayalew, Solary, Eric, Patnaik, Mrinal M.
Publicado 2021

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis

por Tefferi, Ayalew, Guglielmelli, Paola, Nicolosi, Maura, Mannelli, Francesco, Mudireddy, Mythri, Bartalucci, Niccolo, Finke, Christy M., Lasho, Terra L., Hanson, Curtis A., Ketterling, Rhett P., Begna, Kebede H., Naseema Gangat, Pardanani, Animesh, Vannucchi, Alessandro M.
Publicado 2018

AKT is a therapeutic target in myeloproliferative neoplasms

por Khan, Irum, Huang, Zan, Wen, Qiang, Stankiewicz, Monika J., Gilles, Laure, Goldenson, Benjamin, Schultz, Rachael, Diebold, Lauren, Gurbuxani, Sandeep, Finke, Christy M., Lasho, Terra L., Koppikar, Priya, Pardanani, Animesh, Stein, Brady, Altman, Jessica K., Levine, Ross L., Tefferi, Ayalew, Crispino, John D.
Publicado 2013

Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia

por Binder, Moritz, Carr, Ryan M., Lasho, Terra L., Finke, Christy M., Mangaonkar, Abhishek A., Pin, Christopher L., Berger, Kurt R., Mazzone, Amelia, Potluri, Sandeep, Ordog, Tamas, Robertson, Keith D., Marks, David L., Fernandez-Zapico, Martin E., Gaspar-Maia, Alexandre, Patnaik, Mrinal M.
Publicado 2022

Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts

por Mangaonkar, Abhishek A., Lasho, Terra L., Finke, Christy M., Gangat, Naseema, Al-Kali, Aref, Elliott, Michelle A., Begna, Kebede H., Alkhateeb, Hassan, Wolanskyj-Spinner, Alexandra P., Hanson, Curtis A., Ketterling, Rhett P., Hogan, William J., Pardanani, Animesh, Litzow, Mark R., Tefferi, Ayalew, Patnaik, Mrinal M.
Publicado 2018